Ac4C adds a new letter to the mRNA medicine lexicon.

Therapeutic mRNAs rely heavily on the incorporation of the RNA modification N1- methylpseudouridine for their efficacy. Schiffers et al. present N4-acetylcytidine as a robust alternative that further enhances protein production, broadening the chemical repertoire available for designing the next generation of mRNA medicines.1.